Abstract
Chronic intermittent hypoxia (CIH) is the main pathophysiological feature of obstructive sleep apnea (OSA). It destroys the normal sleep rhythm and affects many basic physiological processes, leading to repeated arousal from sleep. Orexin, a very potent arousal neuromodulator found in the brain, has been shown to play a significant role in the promotion and maintenance of arousal. These findings may indicate that orexin participates in the arousal-promoted processes induced by CIH. However, so far, little is known about alterations in orexin and its receptors during CIH. In the present study, the influence of CIH and re-oxygenation on the expression of prepro-orexin (PPO) in the hypothalamus and orexin receptors in the hypothalamus and the medulla of rats were evaluated. The expression of PPO, OX1R, and OX2R mRNA was evaluated by RT-PCR after the rats had been exposed to intermittent hypoxia (IH) for either 1 week or 5 weeks. The control group was exposed to intermittent air (IA). The results showed the levels of expression of PPO, OX1R, and OX2R mRNA to be significantly higher in the brains of rats exposed to IH for 5 weeks than in the brains of control rats. This effect was reversed by 5 weeks of re-oxygenation. These findings indicated that CIH could increase the expression of orexin and its receptors in the brain. This may contribute to the sleep fragmentation experienced by patients with OSA, which is induced by repeated arousal.
Similar content being viewed by others
References
Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population heath perspective. Am. J. Respir. Crit. Care Med. 2002; 165 (9): 1217–39.
White DP. Sleep-related breathing disorder, 2: pathophysiology of obstructive sleep apnoea. Thorax 1995; 50: 797–804.
Naegele B, Thouvard V, Pepin JL et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 1995; 18: 43–52.
Row BW, Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am. J. Respir. Crit. Care Med. 2003; 167: 1548–53.
Li G, Hou G, Lu W, Kang J. Melatonin protects mice with intermittent hypoxia from oxidative stress-induced pancreatic injury. Sleep Biol. Rhythms 2011; 9: 78–85.
Fletcher EC, Lesske J, Qian W, Miller CC, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992; 19: 555–61.
Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat. Rev. Cardiol. 2010; 7: 677–85.
Valenza MC, Valenza G, Munoz-Casaubon T et al. Epidemiology of sleep-related complaints associated with obstructive sleep apnea, insomnia and non-restorative sleep in an at-risk population in Granada, Spain. Sleep Biol. Rhythms 2012; 10: 222–30.
Vakulin A, Catcheside PG, van den Heuvel CJ, Antic NA, Mcevoy RD, Baulk SD. Increased rate of traffic law infringements during on-road metropolitan driving in obstructive sleep apnea patients. Sleep Biol. Rhythms 2011; 9: 144–9.
Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population based sample of employed adults. Sleep 1997; 20: 608–13.
de Lecea L, Kilduff TS, Peyron C et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. U.S.A. 1998; 95: 322–7.
Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 2007; 8: 171–81.
Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39–40.
Igarashi N, Tatsumi K, Nakamura A et al. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome. Chest 2003; 124: 1381–5.
Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999; 827: 243–60.
White DP. The pathogenesis of obstructive sleep apnea: advances in the past 100 years. Am. J. Respir. Cell Mol. Biol. 2006; 34: 1–6.
Fung SJ, Yamuy J, Sampogna S, Morales FR, Chase MH. Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a doble-labeling immunohistochemical study. Brain Res. 2001; 903: 257–62.
Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: 862–5.
Gu CJ, Li M, Li QY, Li N. Chronic intermittent hypoxia increases beta cell mass and activates the mammalian target of rapamycin/hypoxia inducible factor 1/vascular endothelial growth factor A pathway in mice pancreatic islet. Chin. Med. J. 2013; 126: 2368–73.
Wu XD, Huang JH, Kong DH et al. Establishment of a rat chronic intermittent hypoxia model and evaluation by echocardiogram. Fudan Univ. J. Med. Sci. 2011; 38: 481–4.
Liu ZB, Song NN, Geng WY et al. Orexin-A and respiration in rat model of smoke-incuced chronic obstructive pulmonary disease. Clin. Exp. Pharmacol. Physiol. 2010; 37: 963–8.
Huang ZL, Qu WM, Li WD et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl Acad. Sci. U.S.A. 2001; 98: 9965–70.
Thannickal TC, Moore RY, Nienhuis R et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469–74.
Dempsey JA, Veasey SC, Morgan BJ, O’Doneel CP. Pathophysiology of sleep apnea. Physiol. Rev. 2010; 90: 47–112.
Busquets X, Barbe F, Barcelo A et al. Decreased plasma levels of orexin-A in sleep apnea. Respiration 2004; 71: 575–9.
Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H, Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J. Appl. Physiol. (1985) 1992; 72: 1978–84.
Arnardottir ES, Machiewicz M, Gislason T, Teff KL, Pack AL. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009; 32: 447–70.
Wang W, Li Q, Pan Y, Zhu D, Wang L. Influence of hypercapnia on the synthesis of neuropeptides and their receptors. Respirology 2013; 18: 102–7.
Willie JT, Chemelli RM, Sinton CM et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003; 38: 715–30.
Sunanaga J, Deng BS, Zhang W, Kanmura Y, Kuwaki T. CO2 activates orexin-containing neurons in mice. Respir. Physiol. Neurobiol. 2009; 166: 184–6.
Williams RH, Jensen LT, Verkhratsky A, Fugger L, Burdakov D. Control of hypothalamic orexin neurons by acid and CO2. Proc. Natl Acad. Sci. U.S.A. 2007; 104: 10685–90.
Machaalani R, Hunt NJ, Waters KA. Effects of changes in energy homeostasis and exposure of noxious insults on the expression of orexin (hypocretin) and its receptors in the brain. Brain Res. 2013; 1526: 102–22.
Yuan LB, Dong HL, Zhang HP et al. Neuroprotective effect of orexin-A is mediated by an increase of hypoxiainducible factor-1 activity in rat. Anesthesiology 2011; 114: 340–54.
Semenza GL, Prabhakar NR. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid. Redox Signal. 2007; 9: 1391–6.
Dutschann M, Kron M, Mörschel M, Gestreau C. Activation of orexin B receptors in the pontine Kölliker-Fuse nucleus modulates pre-inspiratory hypoglossal motor activity in rat. Respir. Physiol. Neurobiol. 2007; 159: 232–5.
Volgin DV, Saghir M, Kubin L. Developmental changes in the orexin 2 receptor mRNA in hypoglossal motoneurons. Neuroreport 2002; 13: 433–6.
Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T. Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice. J. Appl. Physiol. 2007; 102: 241–8.
Kuwaki T. Orexinergic modulation of breathing across vigilance states. Respir. Physiol. Neurobiol. 2008; 164: 204–12.
Zhu LL, Zhao T, Li HS et al. Neurogenesis in the adult rat brain after intermittent hypoxia. Brain Res. 2005; 1055: 1–6.
Arendt DH, Ronan PJ, Oliver KD, Callahan LB, Summers TR, Summers CH. Depressive behavior and activation of the orexin/hypocretin system. Behav. Neurosci. 2013; 127: 86–94.
Li A, Hindmarch CC, Nattie EE, Paton JF. Antagonism of orxin receptors significantly lowers blood pressure in spontaneously hypertensive rats. J. Physiol. 2013; Epub ahead of print.
Tsuneki H, Wada T, Sasaoka T. Role of orexin in the central regulation of glucose and energy homeostasis. Endocr. J. 2012; 59: 365–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Z., Jiang, L., Zhu, F. et al. Chronic intermittent hypoxia and the expression of orexin and its receptors in the brains of rats. Sleep Biol. Rhythms 12, 22–29 (2014). https://doi.org/10.1111/sbr.12043
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1111/sbr.12043